Enviva Inc.
EVA · NYSE
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | -0.04 | 0.06 | -0.08 |
| FCF Yield | -184.69% | -23.56% | -8.99% | -2.07% |
| EV / EBITDA | -5.72 | -448.97 | 745.90 | -188.07 |
| Quality | ||||
| ROIC | -20.09% | -1.83% | -1.31% | -2.54% |
| Gross Margin | -86.11% | 16.35% | 13.83% | -6.99% |
| Cash Conversion Ratio | 0.09 | 0.65 | 0.04 | -0.27 |
| Growth | ||||
| Revenue 3-Year CAGR | 5.02% | 2.81% | 3.35% | 7.43% |
| Free Cash Flow Growth | 1.58% | -96.25% | -65.59% | 56.46% |
| Safety | ||||
| Net Debt / EBITDA | -5.51 | -333.99 | 500.65 | -82.37 |
| Interest Coverage | -8.42 | -0.99 | -0.93 | -0.84 |
| Efficiency | ||||
| Inventory Turnover | 8.34 | 1.39 | 1.31 | 1.55 |
| Cash Conversion Cycle | 77.49 | 104.72 | 98.18 | 93.42 |